Robert J. Mauthe - Concepedia

Author

Robert J. Mauthe

Also Known As

R J Mauthe, R. Mauthe, R.J Mauthe, R.J. Mauthe, Robert J Mauthe, Robert J. Mauthe, Robert Mauthe, Syrian Hamster Embryo Assay Working Group

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Lawrence Livermore National Laboratory Pfizer (United States)University of York York District Hospital Roche (Switzerland)

About

Robert J. Mauthe is an author at Lawrence Livermore National Laboratory specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	837
2	Engineering	4	4	165
3	Public Health	3	3	89
4	Natural Sciences	2	2	45
5	Health Sciences	1	1	32

Robert J. Mauthe

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity Lutz Müller, Robert J. Mauthe, Christopher M. Riley, Regulatory Toxicology and Pharmacology BiochemistryDrug ResistanceMedicineDrug PurityToxicology Testing	2006	454
SFTG international collaborative study on in vitro micronucleus test Marilyn J. Aardema, Ronald D. Snyder, Carol S. Spicer, Mutation Research/Genetic Toxicology and Environmental Mutagenesis Vitro Micronucleus TestEngineeringBiomedical EngineeringTissue CultureMicrofluidics	2006	91
MeIQx-DNA adduct formation in rodent and human tissues at low doses Kenneth W. Turteltaub, Robert J. Mauthe, Karen H. Dingley, Mutation research. Fundamental and molecular mechanisms of mutagenesis Knockout MouseAllergyImmunologyHuman TissuesDna Replication	1997	84
Exposure of mammalian cell cultures to benzo[<i>a</i>] and light results in oxidative DNA damage as measured by 8-hydroxydeoxyguanosine formation Robert J. Mauthe, Vanessa M. Cook, Stephanie L. Coffing, Carcinogenesis Dna DamageLight ResultsBap TreatmentRedox BiologyToxicological Mechanism	1995	70
Comparison of DNA-adduct and tissue-available dose levels of MeIQx in human and rodent colon following administration of a very low dose Robert J. Mauthe, Karen H. Dingley, Steven H. Leveson, International Journal of Cancer	1999	54
Comparative biotransformation studies of MeIQx and PhIP in animal models and humans R. Colin Garner, J. Timothy Lightfoot, Belinda C. Cupid, Cancer Letters BiologyGeneticsMeiosisGenetic EngineeringAnimal Models	1999	49
The Syrian Hamster Embryo (SHE) Cell Transformation Assay: Review of the Methods and Results Robert J. Mauthe, David P. Gibson, Roderick T. Bunch, Toxicologic Pathology	2001	48
A preliminary evaluation of accelerator mass spectrometry in the biomedical field Barry Kaye, R. Colin Garner, Robert J. Mauthe, Journal of Pharmaceutical and Biomedical Analysis Biomedical FieldEngineeringAccelerator Mass SpectrometryAnalytical InstrumentationPreliminary Evaluation	1997	37
Comparisons of the binding of [14C]radiolabelled tamoxifen or toremifene to rat DNA using accelerator mass spectrometry Ian N.H. White, Elizabeth A. Martin, Robert J. Mauthe, Chemico-Biological Interactions Endocrine-related CancerAccelerator Mass SpectrometryMedicineBioanalysisRadiopharmaceutical Therapy	1997	36
FDA and industry collaboration: Identifying opportunities to further reduce reliance on nonhuman primates for nonclinical safety evaluations David H. Ackley, Joanne Birkebak, Jörg Blümel, Regulatory Toxicology and Pharmacology Nhp UseNonhuman PrimatesNhp ShortageNonhuman PrimateLaboratory Animal Study	2022	33

Page 1